Lenvatinib plus pembrolizumab in Japanese patients with endometrial cancer: Results from Study 309/KEYNOTE-775.
Cancer Sci
; 113(10): 3489-3497, 2022 Oct.
Article
in En
| MEDLINE
| ID: mdl-35612971
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Endometrial Neoplasms
Type of study:
Clinical_trials
Limits:
Female
/
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
Cancer Sci
Year:
2022
Type:
Article
Affiliation country:
Japan